SGC
CLVS

South Georgia Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

South Georgia Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-200
Closed -$9K – 206
2014
Q3 		$9K Sell
200
-100
-33% -$4.18K 0.01% 149
2014
Q2 		$12K Buy
300
+200
+200% +$10.3K 0.01% 146
2014
Q1 		$7K Buy
+100
New +$7.34K 0.01% 154

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

South Georgia Capital's CLVS Position: Q4 2014 in Review

South Georgia Capital sold out of Clovis Oncology, Inc. (CLVS) in Q4 2014, closing a stake of 200 shares — an estimated $9K sold.

South Georgia Capital first reported a position in CLVS in Q1 2014 and held it in 3 quarters. The position peaked at $12K in Q2 2014. 143 funds tracked by Wall St. Rank hold CLVS as of Q4 2014.

  • South Georgia Capital reported no remaining Clovis Oncology, Inc. position as of Q4 2014 after selling out during the quarter.
  • South Georgia Capital sold 200 Clovis Oncology, Inc. shares in Q4 2014, an estimated $9K.
  • South Georgia Capital first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 3 quarters.
  • South Georgia Capital's Clovis Oncology, Inc. position peaked at $12K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2014.

Based on South Georgia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.